Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
Phase 2
- Conditions
- Sarcoma of Pelvis
- Registration Number
- NCT00181025
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Brief Summary
This study looks at isolated pelvic perfusion and limbs' girdle with 1 mg tumor necrosis factor alpha (TNFa) in the treatment of locally advanced sarcoma of the pelvis and limbs' girdle.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
- Soft tissue or bone sarcomas locally advanced of the pelvis or limbs' girdle
Read More
Exclusion Criteria
- Resectable tumor without mutilation
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Complete response rate on MRI
- Secondary Outcome Measures
Name Time Method Histological response Objective responses Rate of conservative treatments Overall survival and disease free survival Local and systemic toxicity
Trial Locations
- Locations (1)
Institut Gustave-Roussy
🇫🇷Villejuif, France